##### Table of Contents

---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549



---

FORM 10-QSB



---

(Mark One)

|x | QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ---------------------------------------------------------------------------------

FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2006



| ̈ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ----------------------------------------------------------------------------------------

FOR THE TRANSITION PERIOD FROM              TO

Commission File Number: 000-13858



---

MEDICAL SOLUTIONS MANAGEMENT
INC.

(Exact Name Of Registrant As Specified In Its Charter)



---



|                         |  |                                     
|------------------------ |  | ------------------------------------
|Nevada                   |  | 86-0214815                          
|(State of Incorporation) |  | (I.R.S. Employer Identification No.)

237 Cedar Hill Street, Marlborough, Massachusetts 01752

(Address of principal executive offices)(Zip Code)

(508) 597-6300

(Registrants telephone number, including area code)



(Former name, former address and former fiscal year, if changed since last
report)



---

Check whether the
issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.    Yes  x    No ̈

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange
Act).    Yes ̈No  x

As of November 10, 2006, there were 20,446,729 shares of the issuers common stock issued and outstanding.

Transitional Small Business Disclosure Format (Check one):    Yes ̈No  x



---



---

##### Table of Contents

TABLE OF CONTENTS



|        |  |                                                                                                                                |  |     
|------- |  | ------------------------------------------------------------------------------------------------------------------------------ |  | ----
|Section |  | Heading                                                                                                                        |  | Page
|Part I  |  | Financial Information                                                                                                          |  |     
|        |  |                                                                                                                               
|Item 1  |  | Financial Statements                                                                                                           |  |     
|        |  | Balance Sheets (Unaudited)at September 30, 2006                                                                                |  | 1   
|        |  | Statement of Operations (Unaudited)from January 1, 2006 to September 30, 2006, and the comparative period for Fiscal Year 2005 |  | 2   
|        |  | Statement of Cash Flows (Unaudited)from January 1, 2006 to September 30, 2006, and the comparative period for Fiscal Year 2005 |  | 3   
|        |  | Notes to Financial Statements                                                                                                  |  | 4   
|Item 2  |  | Managements Discussion and Analysis or Plan of Operation                                                                      |  | 7   
|Item 3  |  | Controls and Procedures                                                                                                        |  | 19  
|        |  |                                                                                                                               
|Part II |  | Other Information                                                                                                              |  |     
|        |  |                                                                                                                               
|Item 1  |  | Legal Proceedings                                                                                                              |  | 21  
|Item 2  |  | Unregistered Sales of Equity Securities and Use of Proceeds                                                                    |  | 21  
|Item 3  |  | Defaults Upon Senior Notes                                                                                                     |  | 21  
|Item 4  |  | Submission of Matters to a Vote to Security Holders                                                                            |  | 21  
|Item 5  |  | Other Information                                                                                                              |  | 21  
|Item 6  |  | Exhibits and Reports on Form 8-K                                                                                               |  | 22  
|        |  |                                                                                                                               
|        |  | Signatures                                                                                                                     |  | 23  



---

##### Table of Contents

Explanatory Notes

Unless the context otherwise requires, we use the terms Medical Solutions Management, our company, we, us and our in this prospectus to refer to Medical
Solutions Management Inc. and its subsidiaries.

Note on Forward-Looking Information

Except for historical facts, the statements in this quarterly report on Form 10-QSB are forward-looking statements. Forward-looking statements are
merely our current predictions of future events. These statements are inherently uncertain, and actual events could differ materially from our predictions. Important factors that could cause actual events to vary from our predictions include those
discussed under the headings Risk Factors, Managements Discussion and Analysis or Plan of Operations and Business in our Annual Report on Form 10-KSB for fiscal year ended December 31, 2005. We
assume no obligation to update our forward-looking statements to reflect new information or developments. We urge readers to review carefully the risk factors described in the Annual Report on Form 10-KSB for fiscal year ended December 31, 2005
and the other documents that we file with the SEC. You can read these documents at www.sec.gov



---

##### Table of Contents

PART I FINANCIAL INFORMATION

Medical Solutions Management Inc.

(Formerly China Media Networks International, Inc.)

Consolidated Balance Sheet (unaudited)

September 30, 2006



|                                                                                      |  |                        |            |  
|------------------------------------------------------------------------------------- |  | ---------------------- | ---------- | -
|                                                                                      |  | As ofSeptember 30,2006 |           
|Assets                                                                                |  |                        |            |  
|Current Assets                                                                        |  |                        |            |  
|Cash & cash equivalents                                                               |  | $                      | 646,558    |  
|Accounts receivable, net                                                              |  |                        | 275,820    |  
|Inventory                                                                             |  |                        | 123,716    |  
|Prepaid expenses                                                                      |  |                        | 41,906     |  
|                                                                                      |  |                        |            |  
|Total current assets                                                                  |  |                        | 1,088,000  |  
|                                                                                      | 
|Property & equipment (net)                                                            |  |                        | 102,546    |  
|                                                                                      |  |                        |            |  
|Total assets                                                                          |  | $                      | 1,190,546  |  
|                                                                                      | 
|Liabilities & Stockholders Equity                                                    |  |                        |            |  
|Current Liabilities:                                                                  |  |                        |            |  
|Accounts payable                                                                      |  | $                      | 188,800    |  
|Accrued expenses                                                                      |  |                        | 201,346    |  
|Demand notes                                                                          |  |                        | 0          |  
|Advances from related parties                                                         |  |                        | 0          |  
|Convertible notes payable                                                             |  |                        | 25,000     |  
|                                                                                      |  |                        |            |  
|Total current liabilities                                                             |  |                        | 415,146    |  
|                                                                                      | 
|Convertible notes payable long term (net)                                            |  |                        | 1,260,878  |  
|                                                                                      |  |                        |            |  
|Total long-term liabilities                                                           |  |                        | 1,260,878  |  
|                                                                                      |  |                        |            |  
|Total Liabilities                                                                     |  |                        | 1,676,024  |  
|                                                                                      | 
|Stockholders Equity:                                                                 |  |                        |            |  
|Preferred stock-5,000,000 authorized $0.001 par value                                 |  |                        | 0          |  
|Common stock-100,000,000 authorized $0.0001 par value 20,446,729 issued & outstanding |  |                        | 2,044      |  
|Treasury Stock                                                                        |  |                        | (898,327   | )
|Additional paid in capital                                                            |  |                        | 4,107,343  |  
|Accumulated Deficit                                                                   |  |                        | (3,696,538 | )
|                                                                                      |  |                        |            |  
|Total Stockholders Equity                                                            |  |                        | (485,478   | )
|                                                                                      |  |                        |            |  
|Total Liabilities & Equity                                                            |  | $                      | 1,190,546  |  

See Notes to Unaudited Interim Financial Statements.



1



---

##### Table of Contents

Medical Solutions Management Inc.

(Formerly China Media Networks International, Inc.)

Consolidated Statement of Operations from January 1, 2006 to September 30, 2006 (unaudited)

and the comparative period for Fiscal Year 2005



|                                                   |  |                                     |            |   |                                 |   |            |                                     |  |   |                                  |   |  |   |            |  
|-------------------------------------------------- |  | ----------------------------------- | ---------- | - | ------------------------------- | - | ---------- | ----------------------------------- |  | - | -------------------------------- | - |  | - | ---------- | -
|                                                   |  | Nine MonthsEnded September 30, 2006 |            |   | Nine MonthsEnded October 1,2005 |   |            | Three MonthsEndedSeptember 30, 2006 |  |   | Three MonthsEnded October 1,2005 |  
|Revenue:                                           |  |                                     |            |   |                                 |   |            |                                     |  |   |                                  |   |  |   |            |  
|Sales                                              |  | $                                   | 685,704    |   |                                 | $ | 287,146    |                                     |  | $ | 278,538                          |   |  | $ | 139,246    |  
|                                                   |  |                                     |            |   |                                 |   |            |                                     |  |   |                                  |   |  |   |            |  
|Total revenue                                      |  |                                     | 685,704    |   |                                 |   | 287,146    |                                     |  | $ | 278,538                          |   |  | $ | 139,246    |  
|                                                   |  |                                     |            |   |                                 |   |            |                                     |  |   |                                  |   |  |   |            |  
|Cost of Sales:                                     |  |                                     |            |   |                                 |   |            |                                     |  |   |                                  |   |  |   |            |  
|Cost of goods & services                           |  |                                     | 544,834    |   |                                 |   | 202,543    |                                     |  |   | 205,648                          |   |  |   | 100,256    |  
|                                                   |  |                                     |            |   |                                 |   |            |                                     |  |   |                                  |   |  |   |            |  
|Costs Applicable to Sales & Revenue                |  |                                     | 544,834    |   |                                 |   | 202,543    |                                     |  |   | 205,648                          |   |  |   | 100,256    |  
|                                                   |  |                                     |            |   |                                 |   |            |                                     |  |   |                                  |   |  |   |            |  
|Gross Profit                                       |  |                                     | 140,870    |   |                                 |   | 84,603     |                                     |  |   | 72,890                           |   |  |   | 38,990     |  
|                                                   |  |                                     | 20.5       | % |                                 |   | 29.5       | %                                   |  |   | 26.2                             | % |  |   | 28.0       | %
|                                                   |  |                                     |            |  
|Selling, General & Administrative Expenses         |  |                                     | 2,139,893  |   |                                 |   | 406,809    |                                     |  |   | 814,938                          |   |  |   | 202,935    |  
|                                                   |  |                                     |            |   |                                 |   |            |                                     |  |   |                                  |   |  |   |            |  
|Total Operating Expenses                           |  |                                     | 2,139,893  |   |                                 |   | 406,809    |                                     |  |   | 814,938                          |   |  |   | 202,935    |  
|                                                   |  |                                     |            |   |                                 |   |            |                                     |  |   |                                  |   |  |   |            |  
|(Loss) Before Other Income                         |  |                                     | (1,999,023 | ) |                                 |   | (322,206   | )                                   |  |   | (742,048                         | ) |  |   | (163,945   | )
|                                                   |  |                                     |            |  
|Other Income (Expense)                             |  |                                     |            |   |                                 |   |            |                                     |  |   |                                  |   |  |   |            |  
|Interest Income                                    |  |                                     | 12,943     |   |                                 |   | 12         |                                     |  |   | 9,429                            |   |  |   | 0          |  
|                                                   |  |                                     |            |   |                                 |   |            |                                     |  |   |                                  |   |  |   |            |  
|Other Income                                       |  |                                     | 0          |   |                                 |   | 0          |                                     |  |   | 0                                |   |  |   | 0          |  
|                                                   |  |                                     |            |   |                                 |   |            |                                     |  |   |                                  |   |  |   |            |  
|Interest (expense), net                            |  |                                     | (931,316   | ) |                                 |   | 0          |                                     |  |   | (111,172                         | ) |  |   | 0          |  
|                                                   |  |                                     |            |   |                                 |   |            |                                     |  |   |                                  |   |  |   |            |  
|(Loss) Before Income Taxes                         |  |                                     | (2,917,396 | ) |                                 |   | (322,194   | )                                   |  |   | (843,971                         | ) |  |   | (163,945   | )
|                                                   |  |                                     |            |   |                                 |   |            |                                     |  |   |                                  |   |  |   |            |  
|Income Taxes                                       |  |                                     | 669        |   |                                 |   | 0          |                                     |  |   | 0                                |   |  |   | 0          |  
|                                                   |  |                                     |            |   |                                 |   |            |                                     |  |   |                                  |   |  |   |            |  
|Net Loss available to common shareholders          |  | $                                   | (2,918,065 | ) |                                 | $ | (322,194   | )                                   |  | $ | (843,791                         | ) |  | $ | (163,945   | )
|                                                   |  |                                     |            |   |                                 |   |            |                                     |  |   |                                  |   |  |   |            |  
|Basic and Diluted Net Loss Per Common Share        |  | $                                   | (0.14      | ) |                                 | $ | (0.02      | )                                   |  | $ | (0.04                            | ) |  | $ | (0.01      | )
|                                                   |  |                                     |            |  
|Weighted Average Common Shares Outstanding (Basic) |  |                                     | 20,663,215 |   |                                 |   | 16,414,419 |                                     |  |   | 20,446,729                       |   |  |   | 16,414,419 |  

See Notes to Unaudited Interim Financial Statements.



2



---

##### Table of Contents

Medical Solutions Management Inc.

(Formerly China Media Networks International, Inc.)

Consolidated Statement of Cash Flows from January 1, 2006 to September 30, 2006 (unaudited)

and the comparative period for Fiscal Year 2005



|                                                                                                                        |  |                                     |            |   |                                  |   |          |  
|----------------------------------------------------------------------------------------------------------------------- |  | ----------------------------------- | ---------- | - | -------------------------------- | - | -------- | -
|                                                                                                                        |  | Nine MonthsEnded September 30, 2006 |            |   | Nine Months Ended October 1,2005 |  
|Cash Flows from Operating Activities:                                                                                   |  |                                     |            |   |                                  |   |          |  
|Net Income                                                                                                              |  | $                                   | (2,918,065 | ) |                                  | $ | (322,194 | )
|Adjustments required to reconcile net loss to cash flows from operating activities:                                     |  |                                     |            |   |                                  |   |          |  
|Increase in allowance for doubtful accounts                                                                             |  |                                     | 69,557     |   |                                  |   |          |  
|Depreciation & Amortization                                                                                             |  |                                     | 27,790     |   |                                  |   | 3,549    |  
|Non-cash interest expense                                                                                               |  |                                     | 901,166    |   |                                  |   |          |  
|Stock and options issued for services                                                                                   |  |                                     | 102,581    |   |                                  |   |          |  
|Changes in Operating Assets & Liabilities                                                                               |  |                                     |            |   |                                  |   |          |  
|Accounts receivable                                                                                                     |  |                                     | (219,021   | ) |                                  |   | (137,563 | )
|Inventory                                                                                                               |  |                                     | (14,678    | ) |                                  |   | (124,733 | )
|Prepaid expenses                                                                                                        |  |                                     | (14,387    | ) |                                  |   | (21,263  | )
|Accounts payable                                                                                                        |  |                                     | (129,191   | ) |                                  |   | 142,750  |  
|Accrued expenses                                                                                                        |  |                                     | 168,746    |   |                                  |   | 51,995   |  
|Loan payable                                                                                                            |  |                                     |            |   |                                  |   |          |  
|                                                                                                                        |  |                                     |            |   |                                  |   |          |  
|Net cash used by operating activities                                                                                   |  |                                     | (2,025,502 | ) |                                  |   | (407,459 | )
|                                                                                                                        |  |                                     |            |   |                                  |   |          |  
|Cash Flows from Investing Activities:                                                                                   |  |                                     |            |   |                                  |   |          |  
|Purchase of Equipment                                                                                                   |  |                                     | (27,679    | ) |                                  |   | (33,723  | )
|                                                                                                                        |  |                                     |            |   |                                  |   |          |  
|Net cash used by investing activities                                                                                   |  |                                     | (27,679    | ) |                                  |   | (33,723  | )
|                                                                                                                        |  |                                     |            |   |                                  |   |          |  
|Cash Flows from Financing Activities:                                                                                   |  |                                     |            |   |                                  |   |          |  
|Convertible notes payable                                                                                               |  |                                     | 2,000,000  |   |                                  |   | 0        |  
|Proceeds from common stock offering                                                                                     |  |                                     | 0          |   |                                  |   | 445,414  |  
|Purchase of treasury stock                                                                                              |  |                                     | 0          |   |                                  |   | 0        |  
|Payment of offering costs                                                                                               |  |                                     | 0          |   |                                  |   | 0        |  
|Borrowings from related parties                                                                                         |  |                                     | 0          |   |                                  |   | 34,517   |  
|Payment of related party debt                                                                                           |  |                                     | 0          |   |                                  |   | 0        |  
|                                                                                                                        |  |                                     |            |   |                                  |   |          |  
|Net cash used by financing activities                                                                                   |  |                                     | 2,000,000  |   |                                  |   | 479,931  |  
|                                                                                                                        |  |                                     |            |   |                                  |   |          |  
|Net Change In Cash                                                                                                      |  |                                     | (53,181    | ) |                                  |   | 38,749   |  
|Cash-Beginning                                                                                                          |  |                                     | 699,740    |   |                                  |   | 0        |  
|                                                                                                                        |  |                                     |            |   |                                  |   |          |  
|Cash-Ending                                                                                                             |  | $                                   | 646,558    |   |                                  | $ | 38,749   |  
|                                                                                                                        |  |                                     |            |   |                                  |   |          |  
|                                                                                                                        |  |                                    
|See Notes to Interim Financial Statements.                                                                              |  |                                     |            |   |                                  |   |          |  
|                                                                                                                        |  |                                    
|Supplemental disclosure of non-cash transactions:                                                                       |  |                                     |            |   |                                  |   |          |  
|Value of common stock warrants issued for services                                                                      |  |                                     | 87,581     |   |                                  |   | 0        |  
|Value of common stock warrants issued for interest expenses                                                             |  |                                     | 820,144    |   |                                  |   | 0        |  
|Value of discount to convertible debenture arising from computed beneficial conversion feature                          |  |                                     | 820,144    |   |                                  |   | 0        |  
|Return of 1,694,419 of treasury stock based on the reduction of the conversion price on the Vicis convertible debenture |  |                                     | 898,327    |   |                                  |   | 0        |  

See Notes to Unaudited Interim Financial Statements.



3



---

##### Table of Contents

MEDICAL SOLUTIONS MANAGEMENT INC.

NOTES TO UNAUDITED INTERIM FINANCIALS STATEMENTS

1. Basis of Presentation

The Financial Statements presented herein
have been prepared by us in accordance with the accounting policies described in our Annual Report on Form 10-KSB for fiscal year ended December 31, 2005 and should be read in conjunction with the Notes to Consolidated Financial Statements
which appear in that report.

The preparation of these financial statements in conformity with accounting principles generally accepted in the United
States requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on going basis, we evaluate our estimates,
including those related intangible assets, income taxes, insurance obligations and contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the
circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other resources. Actual results may differ from these estimates under different
assumptions or conditions.

In the opinion of management, the information furnished in this Form 10-QSB reflects all adjustments necessary for a fair
statement of the financial position and results of operations and cash flows as of and for the three-month and nine-month periods ended September 30, 2006 and 2005. All such adjustments are of a normal recurring nature. The Consolidated
Financial Statements have been prepared in accordance with the instructions to Form 10-QSB and therefore do not include some information and notes necessary to conform to annual reporting requirements.

2. Earnings/Loss Per Share

Basic earnings per share are computed by
dividing income available to common shareholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) for the period. Diluted earnings per share assume that any dilutive convertible securities outstanding
were converted, with related preferred stock dividend requirements and outstanding common shares adjusted accordingly. It also assumes that outstanding common shares were increased by shares issuable upon exercise of those stock options for which
market price exceeds the exercise price, less shares which could have been purchased by us with the related proceeds. In periods of losses, diluted loss per share is computed on the same basis as basic loss per share as the inclusion of any other
potential shares outstanding would be anti-dilutive.

3. New Accounting Standards

In May 2005, the FASB issued SFAS No. 154, Accounting Changes and Error Corrections, which replaced APB Opinion No. 20 Accounting Changes, and FASB Statement No. 3
Reporting Accounting Changes in Interim Financial Statements, and changed the requirements for the accounting for and reporting of a change in accounting principle. This Statement requires retrospective application to prior periods
financial statements of changes in accounting principle, unless it is impracticable to determine either the period-specific effects or the cumulative effect of the change. This Statement is effective for accounting changes and corrections of errors
made in fiscal years beginning after December 15, 2005. We do not believe that adoption of SFAS 154 will have a material impact on our financial statements.



4



---

##### Table of Contents

4. Stock-Based Compensation-Adoption of SFAS 123R

On January 1, 2006, the Company adopted the provisions of Statement of Financial Accounting Standards (SFAS) 123R, Share-Based Payment (SFAS 123(R)), which requires that
companies measure and recognize compensation expense at an amount equal to the fair value of share-based payments granted under compensation arrangements. Prior to January 1, 2006, the Company accounted for its stock-based compensation plans
under the recognition and measurement principles of Accounting Principles Board (APB) Opinion 25, Accounting for Stock Issued to Employees, and related interpretations, and recognized no compensation expense for stock option
grants since all options granted had an exercise price equal to the market value of the underlying common stock on the date of grant.

The Company adopted
SFAS 123(R) using the modified prospective method, which results in no restatement of prior period amounts. Under this method, the provisions of SFAS 123(R) apply to all awards granted or modified after the date of adoption. In addition,
compensation expense must be recognized for any unvested stock option awards outstanding as of the date of adoption on a straight-line basis over the remaining vesting period. The Company calculates the fair value of options using a Black-Scholes
option pricing model.

SFAS 123(R) also requires the benefits of tax deductions in excess of recognized compensation expense to be reported in the
Statement of Cash Flows as a financing cash inflow rather than an operating cash inflow. In addition, SFAS 123(R) required a modification to the Companys calculation of the dilutive effect of stock option awards on earnings per share. For
companies that adopt SFAS 123(R) using the modified prospective method, disclosure of pro forma information for periods prior to adoption must continue to be made.

As of September 30, 2006, there was no unrecognized compensation cost related to non-vested options granted under the plan. The total fair value of shares issued and vested during the nine-month period ended
September 30, 2006 was $87,581, which represents the expense associated with the issuance of the warrant to FP Associates (none during the nine-month period ended October 1, 2005).

The following table summarizes the status of the Companys aggregate options as of September 30, 2006, including the issuance by the Company of the warrant to
FP Associates:



|                         |  |                     |   |          |                               |                     |                                |      |        |         |                                |   |     
|------------------------ |  | ------------------- | - | -------- | ----------------------------- | ------------------- | ------------------------------ | ---- | ------ | ------- | ------------------------------ | - | ----
|                         |  | Options Outstanding |   | Weighted |                               | Options Exercisable
|Range of exercise prices |  | Shares              |   |          | weightedaverage exerciseprice |                     | averageremaining life inmonths |      | Shares |         | weighted average exerciseprice
|$ .01-$ .74              |  | 900,000             | * |          | $                             | 0.01                |                                | 39.6 |        | 900,000 |                                | $ | 0.01

---

|* | Includes options to purchase an aggregate 600,000 shares of common stock of OrthoSupply Management, Inc., our wholly-owned subsidiary, to be converted to substantially equivalent
options in our Company pursuant to the 2006 Equity Incentive Plan.
|- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



5



---

##### Table of Contents

5. Managements Plan

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in the notes to the unaudited financial statements, the Companys losses have resulted in an accumulated
deficit of $ 2,918,065 for the nine month period ending September 30, 2006, and operating activities consumed $2,025,502 in cash. These conditions raise substantial doubt about our ability to continue as a going concern. Managements plans
in regard to these matters are described in the notes. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Our two main objectives for the next 12 months are to continue our ability to finance the Company and to focus on expanding revenue in key locations across the country. We expect that our current cash availability
will support current operations through the beginning of December 2006. Our current monthly cash burn rate is approximately $250,000. We anticipate that we will need to complete additional financing to support current working capital needs and
potential acquisitions. Through these financings, we hope to expand the business organically and acquisitively.

Our plan for organic growth includes
increasing our sales force in key locations across the country. In fiscal year 2006 and 2007, we plan to build our sales force from our current level, 5 sales people, to 10 sales people. During the third quarter of 2006 we added one regional sales
manager in the Southeast and one regional sales manager will begin at the start of the fourth quarter on the West Coast. The plan includes support programs for the sales efforts including marketing, communications and program literature.

We also plan to increase our resources in administration, and to add one to three additional employees to assist with our service administration. During the nine
months ended September 30, 2006, we hired five additional customer support specialists, one field representative and one regional operations manager in order to carry out our current service model. We expect to hire additional field support
resources to support the growth in new clinics during 2006 and 2007.

We do not anticipate devoting our resources to research and development in fiscal
year 2006 or 2007 at the current time.

We continue to pursue opportunities that will add to our current product and service offerings in an effort to
fulfill the current demands in place, as well as, drive the continuous improvement of the billing and inventory processes that support the clinics.

6.
Subsequent Events

None.



6



---

##### Table of Contents

ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.

The following discussion and
analysis of our financial condition and plan of operations should be read in conjunction with the financial statements and the related notes. This discussion contains forward-looking statements based upon current expectations that involve risks and
uncertainties, such as our plans, objectives, expectations and intentions. Our actual results and the timing of certain events could differ materially from those anticipated in these forward-looking statements as a result of certain factors,
including those set forth in Annual Report on Form 10-KSB for the fiscal year ended December 31, 2005 under Risk Factors, Managements Discussion and Analysis or Plan of Operations and
Business.

Background

On July 31, 2006, we changed our name to Medical Solutions Management Inc. from China Media Networks International, Inc. On December 30, 2005, we consummated a merger transaction with our then wholly-owned subsidiary, CMNW
Acquisition Corporation, OrthoSupply Management, Inc., Thunderbird Global Corporation and Mark L. Baum. Pursuant to the merger, CMNW Acquisition Corporation merged with and into OrthoSupply, CMNW Acquisition Corporation ceased to exist, and
OrthoSupply Management, Inc. continued as the surviving corporation and our wholly-owned subsidiary. OrthoSupply acts as our operating company and we are the parent holding company, and sole stockholder, of OrthoSupply Management, Inc.

Prior to consummation of the merger, we ceased all existing operations effective as of January 14, 2003. OrthoSupply Management, Inc. has
generated revenue from its operations since February 2005. In May and June 2006, we completed debt financings that raised aggregate gross proceeds of $2,000,000, which we intend to use for working capital purposes. The discussion below focuses upon
OrthoSupply Management, Inc.s financial condition, results of operations and liquidity and capital resources.

Our Business

We are a provider of orthopedic and podiatric durable medical equipment, specializing in the provision of services using our turnkey program. Through
our turnkey program, we enable orthopedic and podiatric practices to dispense an array of durable medical equipment directly to their patients during office visits. The system, which is transportable to other types of medical practices, also
provides billing services, inventory management and insurance verifications.

Results of Operations

We operate our business on a calendar year basis, with our fiscal year always ending on December 31 and each quarter ending on the 13thcalendar week.

Three
Months Ended September 30, 2006 Compared to Three Months Ended October 1, 2005

Net Revenue.Set forth below
are the net revenues.



|      |  |                    |         |                |   |          |  |           |         |  |      
|----- |  | ------------------ | ------- | -------------- | - | -------- |  | --------- | ------- |  | -----
|      |  | Three Months Ended |         |                |   |         
|      |  | September 30,2006  |         | October 1,2005 |   | Increase |  | %Increase
|Sales |  | $                  | 278,538 |                | $ | 139,246  |  | $         | 139,292 |  | 100.1



7



---

##### Table of Contents

Net revenues increased in the three months ended September 30, 2006 primarily due to the increase in
the number of clinics operating from 7 in 2005 to 30 in 2006. Expansion into new regions throughout the United States has been driving the factor for the increase in clinics as we continue to grow our operations. A total of 12 clinics were added
during the three months ended September 30, 2006. Three of these new clinics were added in the new Southeast region. Four of the new clinics were added during the last week of the third quarter; therefore the revenue impact of these clinics
will not be realized until the fourth quarter.

Cost of Sales.Set forth below are the cost of sales.



|                            |  |                    |         |             |      |   |                |   |             |  |      |          |  |           |         |  |       |  
|--------------------------- |  | ------------------ | ------- | ----------- | ---- | - | -------------- | - | ----------- |  | ---- | -------- |  | --------- | ------- |  | ----- | -
|                            |  | Three Months Ended |         |             |      |   |                |  
|                            |  | September 30,2006  |         | % ofRevenue |      |   | October 1,2005 |   | % ofRevenue |  |      | Increase |  | %Increase |        
|Costs of Goods and Services |  | $                  | 205,648 |             | 73.8 | % |                | $ | 100,256     |  | 71.9 | %        |  | $         | 105,392 |  | 105.1 | %

The percentage represents the costs associated with the medical supplies and services we
supply to our customers. Cost of sales increased primarily due to the increased sales from the additional operating clinics and the addition of field operations staff compared to the comparative period 2005. Cost of sales as a percentage of revenue
stayed consistent with the figures for the comparative period in 2005.

Operating Expenses.Set forth below are the
operating expenses.



|                             |  |                    |         |             |       |   |                |   |             |  |       |          |  |           |         |  |         |  
|---------------------------- |  | ------------------ | ------- | ----------- | ----- | - | -------------- | - | ----------- |  | ----- | -------- |  | --------- | ------- |  | ------- | -
|                             |  | Three Months Ended |         |             |       |   |                |  
|                             |  | September 30,2006  |         | % ofRevenue |       |   | October 1,2005 |   | % ofRevenue |  |       | Increase |  | %Increase |        
|Salaries and benefits        |  | $                  | 256,507 |             | 92.1  | % |                | $ | 147,632     |  | 106.0 | %        |  | $         | 108,875 |  | 73.7    | %
|Legal, consulting, insurance |  |                    | 262,536 |             | 94.3  |   |                |   | 13,460      |  | 9.7   |          |  |           | 249,076 |  | 1,855.2 |  
|All Other                    |  |                    | 295,895 |             | 106.2 |   |                |   | 41,843      |  | 30.0  |          |  |           | 254,052 |  | 607.2   |  
|                             |  |                    |         |             |       |   |                |   |             |  |       |          |  |           |         |  |         |  
|Operating Expenses           |  | $                  | 814,938 |             | 292.6 | % |                | $ | 202,935     |  | 145.7 | %        |  | $         | 612,003 |  | 301.6   | %

Salaries and Benefits Expense.

Salaries and benefits expense increased due to an increase in sales, administrative and service staff as we continue to grow up our operation. Total
employees for the three months ended September 30, 2005 was 23, compared to 6 in comparative period in 2005. We expect to continue to add additional sales and service support staff as we expand our operation.



8



---

##### Table of Contents

Legal, Consulting & Insurance Expenses.

Legal expense increased dramatically to $193,795 for the three months ended September 30, 2006 compared to $0 for the comparative period in 2005.
These expenses are primarily related to services rendered surrounding the completion of the June 2006 debt financing, associated registration of securities with the SEC, and general counsel for operations. Consulting expense has also increased due
to various independent contractor agreements primarily for sales related services. Insurance expense has also increased to support the various requirements set forth by industry standards and growth of the current business.

All Other Expenses

Recruitment fees
of $37,800, rent of $12,742 and $29,077 of printing expenses related to the forms for new clinics added, marketing program expense of $12,955 as well as general expenses to support a growing operation are the driving factors for the increase in
expenses from 2005 to the comparative period in 2006.

Net Loss. Set forth below is the Net loss.



|         |  |                    |          |   |             |        |   |                |   |          |             |  |        |                    |  |   |                      |   |  |        |  
|-------- |  | ------------------ | -------- | - | ----------- | ------ | - | -------------- | - | -------- | ----------- |  | ------ | ------------------ |  | - | -------------------- | - |  | ------ | -
|         |  | Three Months Ended |          |   |             |        |   |                |  
|         |  | September 30,2006  |          |   | % ofRevenue |        |   | October 1,2005 |   |          | % ofRevenue |  |        | Increase(Decrease) |  |   | % Increase(Decrease) |  
|Net Loss |  | $                  | (843,791 | ) |             | (302.9 | ) |                | $ | (163,945 | )           |  | (117.7 | )                  |  | $ | (679,846             | ) |  | (414.7 | )

The Net loss for the three months ended September 30, 2006 was attributable to selling and
administrative costs as we continue to grow our operations, by introducing new clinics, building a national sales force and hiring organized support for future clinics. Interest expense of $81,022 was recognized due to the amortization of the
discount arising from the computed beneficial conversion feature associated with the senior secured convertible debenture sold to Vicis Capital Master Fund on June 28, 2006. An additional $30,150 of interest expense was recognized as part of
the 6% debenture financing consummated in June 2006.

Our reserve for doubtful accounts. Our reserve amount is based
upon estimated losses for customers who were billed directly for products and services. For the three months ended September 30, 2006, we reserved 14.4% of revenues, or $39,975. The reserve amount is based on the sum of accounts receivable
greater than 120 days. We have added an additional reserve for new business entered into during the month of September 2006. This reserve is based on projected receipts for this new line of business. For the month of September 2006, the reserve
records amounted to $7,965. No reserve was recorded for the comparative period in 2005. We have not written off any accounts receivable to date.

Our reserve for excess or obsolete inventories.We provide reserves for estimated excess, obsolete and shrink during the start-up phase of a clinic. For the three months ended September 30, 2006, we have provided $7,670
for a reserve, as a result of the following method. Our reserve formula, modified during the second quarter of 2006 based on recent experience, is calculated by 25% of the inventory value for operating clinics in the period ended September 30,
2006. No reserve was recorded for the comparative period in 2005.



9



---

##### Table of Contents

Nine Months Ended September 30, 2006 Compared to Nine Months Ended October 1, 2005

Net Revenue.Set forth below are the net revenues.



|      |  |                   |         |                |   |          |  |           |         |  |      
|----- |  | ----------------- | ------- | -------------- | - | -------- |  | --------- | ------- |  | -----
|      |  | Nine Months Ended |         |                |   |         
|      |  | September 30,2006 |         | October 1,2005 |   | Increase |  | %Increase
|Sales |  | $                 | 685,704 |                | $ | 287,146  |  | $         | 398,558 |  | 138.8

Expansion into new regions of the United States and an overall increase in operating clinics of 23
from the comparative period in 2005 is the driving factor in the increase in net revenue. A total of 19 clinics have been added during the nine months ended September 30, 2006.

Cost of Sales. Set forth below are the cost of sales.



|                            |  |                   |         |             |      |   |                |   |             |  |      |          |  |           |         |  |       |  
|--------------------------- |  | ----------------- | ------- | ----------- | ---- | - | -------------- | - | ----------- |  | ---- | -------- |  | --------- | ------- |  | ----- | -
|                            |  | Nine Months Ended |         |             |      |   |                |  
|                            |  | September 30,2006 |         | % ofRevenue |      |   | October 1,2005 |   | % ofRevenue |  |      | Increase |  | %Increase |        
|Costs of Goods and Services |  | $                 | 544,834 |             | 79.5 | % |                | $ | 205,542     |  | 70.5 | %        |  | $         | 339,292 |  | 165.1 | %

Cost of sales increased primarily due to the increased sales from an increase in operating
clinics from the comparative period in 2005. Cost of sales as a percentage of revenue increased slightly due to the addition of field operations staff and the recognition of a reserve for obsolete inventories, both of which were not present in the
comparative period in 2005. These expenses result in $99,807 and $42,190 of additional expense from 2005, respectively.

Operating Expenses. Set forth below are the operating expenses.



|                             |  |                   |           |             |       |   |                |   |             |  |       |          |  |           |           |  |         |  
|---------------------------- |  | ----------------- | --------- | ----------- | ----- | - | -------------- | - | ----------- |  | ----- | -------- |  | --------- | --------- |  | ------- | -
|                             |  | Nine Months Ended |           |             |       |   |                |  
|                             |  | September 30,2006 |           | % ofRevenue |       |   | October 1,2005 |   | % ofRevenue |  |       | Increase |  | %Increase |          
|Salaries and benefits        |  | $                 | 687,593   |             | 100.2 | % |                | $ | 255,677     |  | 89.0  | %        |  | $         | 431,916   |  | 168.9   | %
|Legal, consulting, insurance |  |                   | 807,097   |             | 117.7 |   |                |   | 29,700      |  | 10.3  |          |  |           | 777,397   |  | 2,617.5 |  
|All Other                    |  |                   | 645,203   |             | 94.1  |   |                |   | 121,432     |  | 42.3  |          |  |           | 523,771   |  | 431.3   |  
|                             |  |                   |           |             |       |   |                |   |             |  |       |          |  |           |           |  |         |  
|Operating Expenses           |  | $                 | 2,139,893 |             | 312.0 | % |                | $ | 406,809     |  | 141.6 | %        |  | $         | 1,733,084 |  | 426.0   | %

Salaries and Benefits Expense.

Salaries and benefits expense increased due to an increase in sales, administrative and service staff as we continue to grow up our operation. Total
employees for the comparative period in 2005 were 6, compared to 23 in 2006. We expect to continue to add additional sales and service support staff as we



10



---

##### Table of Contents

expand our operation. We anticipate hiring additional support staff in 2007 based on increase in clinics participating in the program. Our initial estimates
are to hire additional support personnel as dictated by the clinic profiles.

Legal, Consulting & Insurance Expenses.

Legal expense increased dramatically to $538,576 for the period ended September 30, 2006 compared to $0 for the comparative period
in 2005. These expenses are primarily related to services rendered surrounding the various capital/debt financings, associated registration of our securities with the SEC, and general counsel for operations. Consulting expense has also increased due
to various independent contractor agreements, such as the $87,581 recognized for the valuation of warrants issued to FP Associates, for services rendered for financing arrangements and potential acquisitions. Insurance expenses have also increased
to $52,542 in 2006 compared to $13,055 in 2005, to support the growth of the business in 2006.

All Other Expenses

Recruitment fees of $61,280, rent of $55,114 and $63,000 of expenses related to the debt financing in June 2006, increases in travel expenses as well as
general expenses to support a growing operation are the driving factors for the increase in other expenses from 2005 to the comparative period in 2006. Billing service fees have also increased from $11,724 in 2005 to $40,648 for the nine months
ended September 30, 2006, again resulting from the increase in operating clinics for the comparative periods.

Net Loss.Set forth below is the net loss.



|         |  |                   |            |   |             |        |   |                |   |          |             |  |        |                    |  |   |                      |   |  |        |  
|-------- |  | ----------------- | ---------- | - | ----------- | ------ | - | -------------- | - | -------- | ----------- |  | ------ | ------------------ |  | - | -------------------- | - |  | ------ | -
|         |  | Nine Months Ended |            |   |             |        |   |                |  
|         |  | September 30,2006 |            |   | % ofRevenue |        |   | October 1,2005 |   |          | % ofRevenue |  |        | Increase(Decrease) |  |   | % Increase(Decrease) |  
|Net Loss |  | $                 | (2,918,065 | ) |             | (425.6 | ) |                | $ | (322,194 | )           |  | (112.2 | )                  |  | $ | (2,595,871           | ) |  | (805.7 | )

This loss was attributable to selling and administrative costs as we continued to grow our
operations, introducing new clinics, building a national sales force and hiring organized support for future clinics. A one time aggregate charge of $820,144 for interest expense was realized in June 2006 due to the discount arising from the
computed beneficial conversion feature associated with the senior secured convertible debenture sold to Vicis Capital Master Fund on June 28, 2006. We are required to expense the entire amount due to the conversion feature of the debenture
being convertible immediately at the discretion of the note holder. We also recognized $820,144 of a discount to the debenture, which will be amortized using the effective interest method over the two year period of the note. An additional $81,022
of interest expense resulting from the amortization of the discount on the debenture has also been recognized to thru the nine months ending September 30, 2006.

Liquidity and Capital Resources

Cash used in operations during the nine months ended
September 30, 2006 was $2,025,502, compared to $372,942 in the comparative period in 2005; however, financing activities from the $2,000,000 senior convertible debenture consummated on June 28, 2006, resulted in an overall net change in
cash of only ($53,181). Comparatively, borrowings from related parties in the amount of $445,414 in 2005, resulted in a net change in cash of $38,748 for the comparative period in 2005. As of September



11



---

##### Table of Contents

30, 2006 we had $1,190,546 in total assets, compared to $352,482 in 2005, of which $646,558, $38,748 in 2005, was in cash and cash equivalents, and our total
liabilities were $1,676,024, compared to $229,262 in 2005. We expect that our current cash availability will support current operations through the beginning of December 2006 based on our current cash burn rate of $250,000 per month. We anticipate
that we will need to complete additional financing to support current working capital needs and potential acquisitions. Through these financings, we hope to expand the business organically and acquisitively.

Our reserve for doubtful accounts. Our reserve amount is based upon estimated losses for customers who were billed directly for
products and services. For the nine months ended September 30, 2006, we reserved 12% of revenues, or $81,585. The reserve amount is based on the sum of accounts receivable greater than 120 days. We have added an additional reserve for new
business entered into during the month of September 2006, this reserve is based on projected receipts for this new line of business. For the month of September 2006, the reserve records amounted to $7,965. No reserve was recorded for the comparative
period in 2005. We have not written off any accounts receivable to date.

Our reserve for excess or obsolete inventories.We
provide reserves for estimated excess, obsolete and shrink during the start-up phase of a clinic. For the nine months ended September 30, 2006, we have provided $42,338 for a reserve, as a result of the following method. Our reserve formula,
modified during the second quarter of 2006 based on recent experience, is calculated by 25% of the inventory value for operating clinics in the period ended September 30, 2006. No reserve was recorded fro the comparative period in 2005.

Plan of Operations

The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in the notes to the unaudited financial statements, the Companys losses have resulted in an accumulated deficit of
$2,918,065 for the nine month period ending September 30, 2006, and operating activities consumed $2,025,502 in cash. These conditions raise substantial doubt about our ability to continue as a going concern. Managements plans in regard
to these matters are described in the notes. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Our main objectives for the next 12 months are to continue our ability to finance the Company and to focus on expanding revenue in key locations across the country. We are currently pursuing additional follow-on
financing to support current working capital needs and potential acquisitions. We expect that our current cash availability will support current operations through the beginning of December 2006, based on our current monthly burn rate of
approximately $250,000. Through these financings, we hope to expand the business organically and acquisitively.

Our plan for organic
growth includes increasing our sales force in key locations across the country. For the remainder of fiscal year 2006 and into fiscal year 2007, we plan to build our sales force from our current level of 5 sales people to 10 regional sales people.
During the third quarter we added one regional sales manager in the Southeast and one regional sales manager will begin at the start of the fourth quarter on the West Coast. The plan includes support programs for the sales efforts including
marketing, communications and program literature.



12



---

##### Table of Contents

We also plan to increase our resources in administration, and to add one to three additional employees to
assist with our service administration. During the nine months ended September 30, 2006, we hired five additional customer support specialists, one field representative and one regional operations manager in order to carry out our current
service model. We expect to hire additional field support resources to support the growth in new clinics during 2006 and 2007.

We do not
anticipate devoting our resources to research and development in fiscal year 2006 and 2007 at the current time.

We continue to pursue
opportunities that will add to our current product and service offerings in an effort to fulfill the current demands in place, as well as, drive the continuous improvement of the billing and inventory processes that support the clinics.Beginning in the fourth quarter of 2006, we will be entering into agreements to expand our support for clinics servicing workers compensation claims.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of
operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make
estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to
contractual allowances, doubtful accounts, inventories, rebates, product returns, warranty obligations, income taxes, intangibles and investments. We base our estimates on historical experience and on various other assumptions that we believe
to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these
estimates under different assumptions or conditions.

We believe the following critical accounting policies affect our more significant
judgments and estimates used in the preparation of our consolidated financial statements, and this discussion and analysis of our financial condition and results of operations.

Principles of Consolidation: The September 30, 2006 financial statements include the accounts of Medical
Solutions Management Inc. and its wholly-owned subsidiary OrthoSupply Management, Inc. All significant inter-company balances and transactions have been eliminated in consolidation.

Use of Estimates: The preparation of financial statements in conformity with generally accepted accounting principles requires our
management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during
the reporting period. Actual results could differ from the estimates.

Cash and Cash Equivalents: For financial statement
presentation purposes, we consider those short-term, highly liquid investments with original maturities of three months or less to be cash or cash equivalents.

Fair Value of Financial Instruments: Our financial instruments consist of cash and cash equivalents, trade accounts receivable, accounts payable, accrued expenses, and long and short-term borrowings. The
fair value of these instruments approximates their recorded value. We do not have financial instruments with off-balance sheet risk. The fair value estimates were based on market information available to management as of September 30, 2006.



13



---

##### Table of Contents

Financial instruments that potentially subject us to concentrations of market/credit risk consist
principally of cash and cash equivalents and trade accounts receivable. We invest cash through a high credit-quality financial institution, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such
accounts.

A concentration of credit risk may exist with respect to trade receivables. We perform ongoing credit evaluations of customers
and generally do not require collateral from our customers. We review accounts receivable on a regular basis to determine if any such amounts may be potentially uncollectible. We establish a general reserve based on a range of percentages applied to
accounts receivable aging categories. These percentages are based on historical collection and write-off experience. We include any balances that are determined to be uncollectible, along with the general reserve, in the overall allowance for
doubtful accounts. After all attempts to collect a receivable have failed, the receivable is written off against the allowance. Based on our best estimate, we believe the allowance for doubtful accounts of $81,585 is adequate as presented.
Historically, we have not experienced significant losses related to receivables from individual customers or groups of customers in any particular industry or geographic area.

Accounting For Obligations And Instruments Potentially To Be Settled In The Companys Own Stock: We account for obligations and
instruments potentially to be settled in the Companys stock in accordance with EITF Issue No. 00-19, Accounting for Derivative Financial Instruments Indexed To, and Potentially Settled In a Companys Own Stock. This issue addresses the
initial balance sheet classification and measurement of contracts that are indexed to, and potentially settled in, the Companys own stock.

Under EITF Issue No. 00-19 contracts are initially classified as equity or as either assets or liabilities, in the following situations:

Equity



| |  |  | Contracts that require physical settlement or net-share settlement; and
| | - |  | -----------------------------------------------------------------------



| |  |  | Contracts that give the company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement), assuming that all the criteria for
equity classification have been met.
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Assets or Liabilities



| |  |  | Contracts that require net-cash settlement (including a requirement to net-cash settle the contract if an event occurs and if that event is outside the control of the company); and
| | - |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | Contracts that give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------------

All contracts are initially measured at fair value and subsequently accounted for based on the current classification. Contracts initially classified as
equity do not recognize subsequent changes in fair value as long as the contracts continue to be classified as equity. For contracts classified as assets or liabilities, the Company reports changes in fair value in earnings and discloses these
changes in the financial statements as long as the contracts remain classified as assets or liabilities. If contracts classified as assets or liabilities are ultimately settled in shares, any previously reported gains or losses on those contracts
continue to be included in earnings. The classification of a contract is reassessed at each balance sheet date.

In accordance with EITF
Issue No. 00-19, a transaction which includes a potential for net-cash settlement, including liquidated damages, requires that derivative financial instruments, including



14



---

##### Table of Contents

warrants and additional investment rights, initially be recorded at fair value as an asset or liability and subsequent changes in fair value be reflected in
the statement of operations. The recorded value of the liability for such derivatives can fluctuate significantly based on fluctuations in the market value of the underlying common stock of the issuer of the derivative instruments, as well as in the
volatility of the stock price during the term used for observation and the remaining term.

Warrant Derivative Liabilities:
We account for warrants issued in connection with financing arrangements in accordance with EITF Issue No. 00-19, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Companys Own Stock. Pursuant to EITF
Issue No. 00-19, an evaluation of specifically identified conditions is made to determine whether the fair value of warrants issued is required be classified as a derivative liability. The fair value of warrants classified as derivative liabilities
is adjusted for changes in fair value at each reporting period, and the corresponding non-cash gain or loss is recorded in current period earnings.

Property and Equipment: Property and equipment are recorded at cost. Depreciation is computed using the straight line balance method over the estimated useful lives of the assets, generally 5 years. Expenditures for renewals
and betterments are capitalized. Expenditures for minor items, repairs and maintenance are charged to operations as incurred. Gain or loss upon sale or retirement due to obsolescence is reflected in the operating results in the period the event
takes place.

Valuation of Long-Lived Assets: We review the recoverability of our long-lived assets, including buildings,
equipment and intangible assets, when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on our ability to recover the carrying value of
the asset from the expected future pre-tax cash flows (undiscounted and without interest charges) of the related operations. If these cash flows are less than the carrying value of such asset, an impairment loss is recognized for the difference
between estimated fair value and carrying value. Our primary measure of fair value is based on discounted cash flows. The measurement of impairment requires management to make estimates of these cash flows related to long-lived assets, as well as
other fair value determinations.

We amortize the costs of other intangibles, if applicable, (excluding goodwill) over their estimated
useful lives unless such lives are deemed indefinite. Amortizable intangible assets are tested for impairment based on undiscounted cash flows and, if impaired, written down to fair value based on either discounted cash flows or appraised values.
Intangible assets with indefinite lives are tested for impairment, at least annually, and written down to fair value as required.

Revenue Recognition: Our principal sources of revenues are from the sale of medical supplies and from providing related management services. Our revenue recognition policies are in compliance with Staff Accounting Bulletin
(SAB) No. 104, Revenue Recognition, SAB No. 101, Revenue Recognition in Financial Statements and EITF Issue No. 00-21, Revenue Arrangements with Multiple Deliverables. Revenue is recognized when
persuasive evidence of an agreement with the customer exists, products are shipped or title passes pursuant to the terms of the agreement with the customer, the amount due from the customer is fixed or determinable, collectibility is reasonably
assured, and there are no significant future performance obligations. Service revenues are recognized at the time of performance and usually billed monthly. Revenues from separate service maintenance agreements are recognized ratably over the term
of the agreements.

These policies require management, at the time of the transaction, to assess whether the amounts due are fixed or
determinable, collection is reasonably assured, and no future performance obligations exist. These assessments are based on the terms of the agreement with the customer, past history and creditworthiness of the customer. If management determines
that collection is not reasonably assured or future performance obligations exist, revenue recognition is deferred until these conditions are satisfied.



15



---

##### Table of Contents

In accordance with EITF Issue 00-10, Accounting for Shipping and Handling Fees and Costs, we
included all shipping and handling billings to customers in revenues, and freight costs incurred for product shipments have been included in cost of products sold.

Our revenue is comprised of 3 main categories: product sales, billing and collection revenue and service revenue. Our product sales are recorded at the end of each month for all the products ordered by each client.
The billing and collection revenue consists of a percentage fee based the reimbursements received by each clinic recognized at the end of each month. Service revenue, also recognized at the end of each month, is the monthly

Income Taxes: We must make certain estimates and judgments in determining income tax expense for financial statement purposes. These
estimates and judgments occur in the calculation of certain tax assets and liabilities, which arise from differences in the timing of recognition of revenue and expense for tax and financial statement purposes.

Deferred income taxes are recorded in accordance with SFAS No. 109, Accounting for Income Taxes , or SFAS 109. Under SFAS
No. 109, deferred tax assets and liabilities are determined based on the differences between financial reporting and the tax basis of assets and liabilities using the tax rates and laws in effect when the differences are expected to reverse.
SFAS 109 provides for the recognition of deferred tax assets if realization of such assets is more likely than not to occur. Realization of our net deferred tax assets is dependent upon our generating sufficient taxable income in future years in
appropriate tax jurisdictions to realize benefit from the reversal of temporary differences and from net operating loss, or NOL, carryforwards. We have determined it more likely than not that these timing differences will not materialize and have
provided a valuation allowance against substantially all of our net deferred tax asset. Management will continue to evaluate the realizability of the deferred tax asset and its related valuation allowance. If our assessment of the deferred tax
assets or the corresponding valuation allowance were to change, we would record the related adjustment to income during the period in which we make the determination. Our tax rate may also vary based on our results and the mix of income or loss in
domestic and foreign tax jurisdictions in which we operate.

In addition, the calculation of our tax liabilities involves dealing with
uncertainties in the application of complex tax regulations. We recognize liabilities for anticipated tax audit issues in the U.S. and other tax jurisdictions based on our estimate of whether, and to the extent to which, additional taxes will be
due. If we ultimately determine that payment of these amounts is unnecessary, we will reverse the liability and recognize a tax benefit during the period in which we determine that the liability is no longer necessary. We will record an additional
charge in our provision for taxes in the period in which we determine that the recorded tax liability is less than we expect the ultimate assessment to be.

Stock-Based Compensation Plans: We account for stock-based compensation using the intrinsic value method prescribed in Accounting Principles Board, or APB, Opinion No. 25, Accounting for
Stock Issued to Employees , or APB 25, and related interpretations. Under APB 25, compensation cost is measured as the excess, if any, of the closing market price of our stock at the date of grant over the exercise price of the option
granted. We recognize compensation cost for stock options, if any, ratably over the vesting period. Generally, we grant options with an exercise price equal to the closing market price of our stock on the grant date. Accordingly, we have not
recognized any compensation expense for our stock option grants. We provide additional pro forma disclosures as required under SFAS No. 123, Accounting for Stock-Based Compensation , or SFAS 123, as amended by SFAS
No. 148, Accounting for Stock-Based Compensation-Transition and Disclosure an Amendment of FASB Statement No. 123 ,



16



---

##### Table of Contents

or SFAS 148, using the Black-Scholes pricing model. We charge the value of the equity instrument to earnings and in accordance with FASB Interpretation
No. 28, Accounting for Stock Appreciation Rights and Other Variable Stock Option or Award Plansan interpretation of APB Opinions No. 15 and 25 . In computing fair value we used the following assumptions:



|     |  |              |   |  |               |   |  |                    |   |  |              
|---- |  | ------------ | - |  | ------------- | - |  | ------------------ | - |  | -------------
|Year |  | InterestRate |   |  | DividendYield |   |  | ExpectedVolatility |   |  | Expected Life
|2006 |  | 4.3          | % |  | 0.0           | % |  | 50.0               | % |  | 60 mos.      

Earnings per Common Share: Basic earnings per share is computed by dividing income
available to common shareholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) for the period. Diluted earnings per share assumes that any dilutive convertible securities outstanding were converted,
with related preferred stock dividend requirements and outstanding common shares adjusted accordingly. It also assumes that outstanding common shares were increased by shares issuable upon exercise of those stock options for which market price
exceeds the exercise price, less shares which could have been purchased by us with the related proceeds. In periods of losses, diluted loss per share is computed on the same basis as basic loss per share as the inclusion of any other potential
shares outstanding would be anti-dilutive.

Recent Accounting Pronouncements

In December 2004, the FASB issued SFAS No. 123 (revised 2004) Share-Based Payment 123(R). SFAS No. 123(R) revises FASB Statement
No. 123 Accounting for Stock-Based Compensation, and supersedes APB Opinion No. 25, and its related implementation guidance. This Statement eliminates the ability to account for share-based compensation using the intrinsic
value method under APB Opinion No. 25. SFAS No. 123(R) focuses primarily on accounting for transactions in which an entity obtains employee services in share-based payment transactions. SFAS No. 123(R) requires a public entity to
measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That cost will be recognized over the period during which an employee is
required to provide service in exchange for the award, known as the requisite service period, which is usually the vesting period. SFAS No. 123(R) is effective for companies filing under Regulation S-B as of the beginning of the first interim
or annual reporting period that begins after December 15, 2005, which for us is our first quarter of the year ending December 31, 2006. We adopted SFAS No. 123(R) beginning January 1, 2006 . Accordingly, the provisions of SFAS
No. 123(R) apply to new awards and to awards modified, repurchased, or cancelled after the effective date. Additionally, compensation cost for the portion of awards for which the requisite service has not been rendered that are outstanding as
of the effective date must be recognized as the requisite service is rendered on or after the required effective date. These new accounting rules will lead to a decrease in reported earnings. Although our adoption of SFAS No. 123(R) could have
a material impact on our financial position and results of operations, we are still evaluating the potential impact from adopting this statement.

EITF Issue 04-8, The Effect of Contingently Convertible Instruments on Diluted Earnings per Share. The EITF reached a consensus that contingently convertible instruments, such as contingently convertible debt, contingently
convertible preferred stock, and other such securities should be included in diluted earnings per share (if dilutive) regardless of whether the market price trigger has been met. The consensus became effective for reporting periods ending after
December 15, 2004. The adoption of this pronouncement does not currently have an effect on our financial statements because the inclusion of common stock equivalents in earnings per share is anti-dilutive.



17



---

##### Table of Contents

In September 2005, the FASB ratified the Emerging Issues Task Forces (EITF) Issue
No. 05-7, Accounting for Modifications to Conversion Options Embedded in Debt Instruments and Related Issues, which addresses whether a modification to a conversion option that changes its fair value affects the recognition of
interest expense for the associated debt instrument after the modification and whether a borrower should recognize a beneficial conversion feature not a debt extinguishment if a debt modification increases the intrinsic value of the debt (for
example, the modification reduces the conversion price of the debt). In September 2005, the FASB also ratified the EITFs Issue No. 05-8, Income Tax Consequences of Issuing Convertible Debt with a Beneficial Conversion
Feature, which discusses whether the issuance of convertible debt with a beneficial conversion feature results in a basis difference arising from the intrinsic value of the beneficial conversion feature on the commitment date (which is treated
recorded in the shareholders equity for book purposes, but as a liability for income tax purposes), and, if so, whether that basis difference is a temporary difference under FASB Statement No. 109, Accounting for Income
Taxes. We are currently in the process of evaluating the effect that the adoption of this pronouncement may have on our financial statements.

In September 2005, the FASB also ratified the EITFs Issue No. 05-8, Income Tax Consequences of Issuing Convertible Debt with a Beneficial Conversion Feature, which discusses whether the
issuance of convertible debt with a beneficial conversion feature results in a basis difference arising from the intrinsic value of the beneficial conversion feature on the commitment date (which is treated recorded in the shareholders equity
for book purposes, but as a liability for income tax purposes), and, if so, whether that basis difference is a temporary difference under FASB Statement No. 109, Accounting for Income Taxes. We currently carry an allowance for
all deferred taxes and, therefore we do not believe the adoption of this pronouncement will have any impact on our financial statements.

In September 2004, the EITF reached a consensus regarding Issue No. 04-1, Accounting for Preexisting Relationships Between the Parties to a Business Combination (EITF 04-1). EITF 04-1 requires an acquirer
in a business combination to evaluate any preexisting relationship with the acquiree to determine if the business combination in effect contains a settlement of the preexisting relationship. A business combination between parties with a preexisting
relationship should be viewed as a multiple element transaction. EITF 04-1 is effective for business combinations after October 13, 2004, but requires goodwill resulting from prior business combinations involving parties with a preexisting
relationship to be tested for impairment by applying the guidance in the consensus. We will apply EITF 04-1 to acquisitions subsequent to the effective date and in our future goodwill impairment testing.

In November 2004, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards (SFAS) No. 151, Inventory
Costs - an amendment of ARB No. 43, Chapter 4, which clarifies the accounting for abnormal amounts of idle facility expense, freight, handling costs and wasted material. SFAS No. 151 is effective for inventory costs incurred during
fiscal years beginning after June 15, 2005. We do not believe the adoption of SFAS No. 151 will have a material impact on our financial statements.

In December 2004, the FASB issued SFAS No. 153, Exchanges of Nonmonetary Assetsan amendment of APB Opinion No. 29, which is effective for us July 1, 2005. In the past, we were
frequently required to measure the value of assets exchanged in non-monetary transactions by using the net book value of the asset relinquished. Under SFAS No. 153, we will measure assets exchanged at fair value, as long as the transaction has
commercial substance and the fair value of the assets exchanged is determinable within reasonable limits. A non-monetary exchange has commercial substance if the future cash flows of the entity are expected to change significantly as a result of the
exchange. The adoption of SFAS No. 153 is not anticipated to have a material effect on our consolidated financial position, results of operations or cash flows.



18



---

##### Table of Contents

In May 2005, the FASB issued SFAS No. 154, Accounting Changes and Error Corrections,
which replaces APB Opinion No. 20 Accounting Changes, and FASB Statement No. 3 Reporting Accounting Changes in Interim Financial Statements, and changes the requirements for the accounting for and reporting of a
change in accounting principle. This Statement requires retrospective application to prior periods financial statements of changes in accounting principle, unless it is impracticable to determine either the period-specific effects or the
cumulative effect of the change. This Statement is effective for accounting changes and corrections of errors made in fiscal years beginning after December 15, 2005. We do not believe that adoption of SFAS 154 will have a material impact on our
financial statements.

Off Balance Sheet Arrangements

We do not have any off balance sheet arrangements.

ITEM 3. CONTROLS AND PROCEDURES.

Evaluation of disclosure controls and procedures.

As required by Rule 13a-15 under the Exchange Act, as of the end of the period covered by this report, we carried out an evaluation
under the supervision and with the participation of our management, including our President and Treasurer (our acting principal executive officer and principal accounting and finance officer), of the effectiveness of the design and operation of our
disclosure controls and procedures. In designing and evaluating our disclosure controls and procedures, we and our management recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance
of achieving the desired control objectives, and our management necessarily was required to apply its judgment in evaluating and implementing possible controls and procedures. The effectiveness of our disclosure controls and procedures and our
internal control over financial reporting is subject to various inherent limitations, including cost limitations, judgments used in decision making, assumptions about the likelihood of future events, the soundness of our systems, the possibility of
human error, and the risk of fraud. Moreover, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions and the risk that the degree of compliance
with policies or procedures may deteriorate over time. Because of these limitations, there can be no assurance that any system of disclosure controls and procedures or internal control over financial reporting will be successful in preventing all
errors or fraud or in making all material information known in a timely manner to the appropriate levels of management.

A control
deficiency exists when the design or operation of a control does not allow management or employees, in the ordinary course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A significant deficiency is a
control deficiency, or combination of control deficiencies, that adversely affects the Companys ability to initiate, authorize, record, process, or report external financial data reliably in accordance with GAAP, such that there is a more than
remote likelihood that a misstatement of the Companys annual or interim financial statements that is more than inconsequential will not be prevented or detected. A material weakness is a control deficiency, or combination of control
deficiencies, that results in more than a remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected.



19



---

##### Table of Contents

Based upon an evaluation conducted for the period ended September 30, 2006, our President and
Treasurer (our acting principal executive officer and principal accounting and finance officer) has concluded that as of the end of the period covered by this report, we have identified the following material weaknesses:



| |  |  | Reliance upon independent financial reporting consultants for review of critical accounting areas and disclosures and material non-standard transactions.
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | A limited number of on-site accounting personnel which results in a lack of segregation of duties necessary for a good system of internal control.
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------

Managements review of our internal controls is on-going and will take whatever measures necessary to reduce the material deficiencies noted.
Implementation of our remediation plan may include hiring additional permanent employees, establishing additional training programs and/or engaging outside expert consultants. The effectiveness of the steps we have taken to date and the steps we are
still in the process of completing is subject to continued management review, and we may make additional changes to our internal controls and procedures. Although we have undertaken the foregoing initiatives, we cannot assure you that we will not in
the future identify further material weaknesses in our internal control over financial reporting that we have not discovered to date. We will continue to review and document our disclosure controls and procedures, including our internal controls and
procedures for financial reporting, on an ongoing basis, and may from time to time make changes aimed at enhancing their effectiveness and to ensure that our systems evolve with our business.

Changes in internal control over financial reporting.

There was no change in our internal control over financial reporting that occurred during the period covered by this report on Form 10-QSB that has materially affected, or is reasonably likely to materially affect,
our internal control over financial reporting.



20



---

##### Table of Contents

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

We are not involved in nor a party to any material legal proceedings.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None.

ITEM 5. OTHER INFORMATION

None.



21



---

##### Table of Contents

ITEM 6.EXHIBITS AND REPORTS FILED ON FORM 8-K



|            |  |                                                                                                                                                                                                       
|----------- |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Exhibit No. |  | Description                                                                                                                                                                                           
|            | 
|3.1         |  | Amended and Restated Articles of Incorporation of the Registrant (incorporated by reference to Appendix A to the Registrants Definitive Information Statement on Schedule 14C filed on
July 11, 2006)
|            | 
|3.2         |  | Amended and Restated Bylaws of the Registrant (incorporated by reference to Appendix C from the Registrants Definitive Information Statement on Schedule 14C filed on July 11,
2006)                 
|            | 
|31.1        |  | Certification of principal executive officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002 (filed herewith)                                                                               
|            | 
|31.2        |  | Certification of principal accounting and finance officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002 (filed herewith)                                                                  
|            | 
|32.1        |  | Certification of principal executive officer and principal accounting and finance officer pursuant to Section 906 of the Sarbanes Oxley Act of 2002 (filed herewith)                                  



22



---

##### Table of Contents

MEDICAL SOLUTIONS MANAGEMENT INC.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.



|                        |  |                                   |  |                                                                          
|----------------------- |  | --------------------------------- |  | -------------------------------------------------------------------------
|                        |  | MEDICAL SOLUTIONS MANAGEMENT INC.
|                        |  |                                  
|Date: November 14, 2006 |  | By:                               |  | /s/ Brian Lesperance                                                     
|                        |  |                                   |  | Brian Lesperance                                                         
|                        |  |                                   |  | President and Treasurer                                                  
|                        |  |                                   |  | (principal executive officer and principal accounting andfinance officer)



23